SOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function
- PMID: 30206184
- DOI: 10.1158/1541-7786.MCR-18-0610
SOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function
Abstract
The presence of cancer stem cells (CSC), which possess the ability of self-renewal and cancer initiation, is correlated with poor prognosis and drug resistance of breast cancer patients. But the molecular regulatory networks for maintenance of CSC function still remain unclear. Here, we identified that an estrogen-inducible gene FXYD3, whose expression is significantly upregulated in ER+ breast CSCs, is a critical player for regulating ER+ breast CSC function. FXYD3 amplification is crucial in mediating tamoxifen resistance in ER+ breast cancer cells. Interestingly, we also find that stem cell-related transcription factor SOX9 directly promotes FXYD3 expression, and FXYD3 is indispensable for SOX9 nucleus localization, thus forming a positive regulatory feedback loop for FXYD3 amplification and function. In terms of mechanism, FXYD3 interacts with Src and ERα to form an activated complex and triggers Src to transduce nongenomic estrogen signaling for facilitating ER+ breast CSCs. Collectively, these results establish a critical role for SOX9/FXYD3/Src axis in boosting nongenomic estrogen signaling and SOX9 nucleus entry, which is required for maintenance of ER+ breast CSCs and endocrine resistance. Targeting FXYD3-mediated pathway might be a promising therapeutic strategy for hormone therapy-refractory ER+ breast cancer. IMPLICATIONS: SOX9/FXYD3/Src axis is critical for promoting CSC function and tamoxifen resistance in ER+ breast cancer.
©2018 American Association for Cancer Research.
Similar articles
-
SOX9: An emerging driving factor from cancer progression to drug resistance.Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188517. doi: 10.1016/j.bbcan.2021.188517. Epub 2021 Jan 29. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33524528 Review.
-
YB-1 interplays with ERα to regulate the stemness and differentiation of ER-positive breast cancer stem cells.Theranostics. 2020 Feb 19;10(8):3816-3832. doi: 10.7150/thno.41014. eCollection 2020. Theranostics. 2020. PMID: 32206124 Free PMC article.
-
SOX9: The master regulator of cell fate in breast cancer.Biochem Pharmacol. 2020 Apr;174:113789. doi: 10.1016/j.bcp.2019.113789. Epub 2020 Jan 3. Biochem Pharmacol. 2020. PMID: 31911091 Free PMC article. Review.
-
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.J Natl Cancer Inst. 2018 Apr 1;110(4). doi: 10.1093/jnci/djx207. J Natl Cancer Inst. 2018. PMID: 29028222
-
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.J Transl Med. 2017 May 4;15(1):97. doi: 10.1186/s12967-017-1192-x. J Transl Med. 2017. PMID: 28472954 Free PMC article.
Cited by
-
Single-Cell Transcription Mapping of Murine and Human Mammary Organoids Responses to Female Hormones.J Mammary Gland Biol Neoplasia. 2024 Jan 30;29(1):3. doi: 10.1007/s10911-023-09553-x. J Mammary Gland Biol Neoplasia. 2024. PMID: 38289401 Free PMC article.
-
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters.J Clin Invest. 2023 Nov 15;133(22):e166666. doi: 10.1172/JCI166666. J Clin Invest. 2023. PMID: 37966117 Free PMC article.
-
SETD5 regulates the OGT-catalyzed O-GlcNAcylation of RNA polymerase II, which is involved in the stemness of colorectal cancer cells.Sci Rep. 2023 Nov 14;13(1):19885. doi: 10.1038/s41598-023-46923-1. Sci Rep. 2023. PMID: 37963940 Free PMC article.
-
TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.PLoS One. 2023 Aug 3;18(8):e0289535. doi: 10.1371/journal.pone.0289535. eCollection 2023. PLoS One. 2023. PMID: 37535601 Free PMC article.
-
Genome-Wide Association Study of Breast Density among Women of African Ancestry.Cancers (Basel). 2023 May 16;15(10):2776. doi: 10.3390/cancers15102776. Cancers (Basel). 2023. PMID: 37345113 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous